Finox AG   Report issue

For profit Phase 3
Founded: Kirchberg Switzerland (2007)
Status: Acquired by Gedeon Richter Ltd. (2016)

Organization Overview

First Clinical Trial
2010
NCT01121666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Finox Biotech Germany GmbH

Active Ingredients

Drugs in Phase 3 Trials (1)

follitropin alfa (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1